GE HealthCare’s manganese-based MRI contrast agent shines in Phase I trial
GE HealthCare has announced positive results from a Phase I study of its manganese-based macrocyclic magnetic resonance imaging (MRI) contrast …
Post
-
-
Study finds 81% of Canadian doctors want legal controls on AI in medicine
Research conducted by US healthcare site, Medscape, has found that 81% of Canadian clinicians believe that a legal framework for …
-
US grants $510m to boost domestic PPE production
The US Government has granted up to $510m to enhance domestic manufacturing of personal protective equipment (PPE). The Biden administration has …
-
Bassett Medical Centre deploys Philips MRI technology
Bassett Medical Centre in Cooperstown, part of Bassett Healthcare Network, has incorporated advanced MRI technology from Philips to improve patient …
-
Medinol’s implants first ChampioNIR stent in Australia
Medinol has announced the first-in-human (FIH) implantation of the ChampioNIR drug-eluting peripheral stent system at Alfred Hospital in Melbourne, Australia. This …
-
Bioretec boosts RemeOs Spinal Interbody Cage development
Bioretec has announced an acceleration in the development of the RemeOs Spinal Interbody Cage, a medical device that is set …
-
FDA greenlights OrthAlign’s handheld Lantern Hip navigation system
OrthAlign has expanded its portfolio of Lantern handheld navigation systems by securing a 510(k) clearance from the US Food and …
-
Medtronic shares dip after FDA tags insulin pump recall as Class I
The US Food and Drug Administration (FDA) has issued a Class I tag to Medtronic’s recall of its MiniMed insulin …
-
NHS launches study of newborn blood test to detect 200 rare conditions
England’s National Health Service (NHS) has kick started a study which will screen up to 100,000 newborn babies for over …
-
FDA clears FluMist nasal influenza vaccine for self-administration
The US Food and Drug Administration (FDA) has given the green light for market clearance to AstraZeneca’s nasal spray vaccine …
-
WHO approves Abbott’s mpox test for emergency use
The World Health Organization (WHO) has approved Abbott Molecular’s mpox diagnostic test, Alinity m MPXV assay, for emergency use. This first …
-
Myriad and Ultima to study UG 100 sequencing platform for genomics clinical tests
Myriad Genetics has announced a collaboration with Ultima Genomics to evaluate the potential of the UG 100 sequencing platform and …
-
Amphix Bio obtains FDA breakthrough device status for bone regeneration product
Amphix Bio has received a breakthrough device designation from the US Food and Drug Administration (FDA) for its drug-device combination …
-
Microbix receives EU accreditations for diagnostic products
Life sciences manufacturer Microbix Biosystem has announced upgrades to its European Union (EU) regulatory compliance for its diagnostic assay quality …
-
IoT Medical Device Companies & Manufacturers
The increase in demand for wearable devices that measure various health parameters such as heart rate, oxygen levels, blood pressure …